About: Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.55 (-1.05%)
BBLGNASDAQBone Biologics Corp
Bone Biologics Corp share price
BBLG price activity
Last Price
$0.550
Change (24hr)
-0.01 USD (-1.05%)
Volume
53.29K
Volume (4w avg)
-
Open
$0.59
Day Range
$0.55 - $0.59
Previous Close
$0.56
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
BBLG price performance
Delayed
09 Sep, 8:00 pm GMT+0
BBLG Market Signals